Cellebrite Ownership
| CLBT Stock | USD 19.01 0.49 2.65% |
Cellebrite |
Cellebrite Stock Ownership Analysis
About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.35. Cellebrite DI had not issued any dividends in recent years. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people. For more info on Cellebrite DI please contact Yossi Carmil at 972 73 394 8000 or go to https://www.cellebrite.com.Besides selling stocks to institutional investors, Cellebrite also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cellebrite's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cellebrite's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cellebrite Quarterly Liabilities And Stockholders Equity |
|
About 50.0% of Cellebrite DI are currently held by insiders. Unlike Cellebrite's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cellebrite's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cellebrite's insider trades
Cellebrite Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cellebrite is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellebrite DI backward and forwards among themselves. Cellebrite's institutional investor refers to the entity that pools money to purchase Cellebrite's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Crescent Park Management, L.p. | 2024-12-31 | 1.9 M | Ashford Capital Management Inc | 2024-12-31 | 1.9 M | Two Sigma Advisers, Llc | 2024-12-31 | 1.8 M | Renaissance Technologies Corp | 2024-12-31 | 1.6 M | Amvescap Plc. | 2024-12-31 | 1.5 M | Phoenix Financial Ltd | 2024-12-31 | 1.4 M | Meitav Dash Investments Ltd | 2024-12-31 | 1.4 M | Two Sigma Investments Llc | 2024-12-31 | 1.3 M | Millennium Management Llc | 2024-12-31 | 1.2 M | True Wind Capital Management, L.p. | 2024-12-31 | 13.9 M | Fmr Inc | 2024-12-31 | 10.6 M |
Cellebrite Outstanding Bonds
Cellebrite issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cellebrite DI uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cellebrite bonds can be classified according to their maturity, which is the date when Cellebrite DI has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Cellebrite Corporate Filings
| 18th of March 2025 Other Reports | ViewVerify | |
6K | 13th of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 12th of February 2025 Other Reports | ViewVerify | |
| 11th of February 2025 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.